How Better Document Workflows Can Support Pharma Compliance
In pharmaceutical manufacturing, compliance is built on evidence. Every batch record, standard operating procedure, validation report and quality investigation forms part of the documented proof that medicines have been developed and manufactured in accordance with regulatory expectations.
As the industry embraces digital transformation, however, maintaining that evidence has become increasingly complex. Pharmaceutical companies now manage thousands of electronic documents across manufacturing sites, quality systems, laboratories, contract manufacturers and global supply chains. While digital workflows can improve efficiency and collaboration, they also create new challenges around document integrity, version control and secure access.
For quality, regulatory affairs and manufacturing teams, the question is no longer whether documents are digital, but whether those digital documents remain controlled throughout their lifecycle.
Why document workflows matter for compliance
Documentation underpins every aspect of pharmaceutical quality management. Regulators expect organisations to demonstrate not only that processes have been followed correctly, but that the supporting records are complete, accurate and protected from inappropriate alteration. Teams can maintain that protection by setting user permissions on PDF files, controlling who is able to edit, copy or print a finalised record after it leaves the approval workflow.
The FDA's guidance on data integrity and CGMP compliance reinforces the ALCOA principles, requiring that regulated records be attributable, legible, contemporaneous, original and accurate. Similarly, the MHRA's GxP Data Integrity Guidance and Definitions expands these expectations through the ALCOA+ framework, emphasising that records should also be complete, consistent, enduring and readily available throughout their retention period.
Increasingly, regulators also expect manufacturers to demonstrate robust governance over electronic documentation. As organisations adopt cloud-based quality systems, digital approvals and remote collaboration, document workflows become just as important as the documents themselves.
Where document processes often break down
Modern pharmaceutical operations generate an enormous volume of documentation. A single commercial product may accumulate thousands of records covering formulation development, validation, environmental monitoring, equipment qualification, batch manufacturing, supplier quality and post-market surveillance.
These documents often move between enterprise quality management systems (eQMS), laboratory information management systems (LIMS), manufacturing execution systems (MES), enterprise resource planning (ERP) platforms and external partners. Every transfer introduces opportunities for inconsistency if document controls are not clearly defined.
Common weaknesses include:
- Multiple versions of the same procedure circulating across departments.
- Manual approval processes that delay document release.
- Employees editing controlled documents outside approved workflows.
- Unrestricted sharing of confidential files with suppliers or contract manufacturing organisations (CMOs).
- Inconsistent naming conventions and storage locations that make records difficult to retrieve during inspections.
- Archived documents remaining editable after formal approval.
While none of these issues necessarily indicates poor manufacturing practice, together they can undermine confidence in the reliability of a company's quality management system.
The ICH Q10 Pharmaceutical Quality System guidelines identify document management as a fundamental component of an effective pharmaceutical quality system, supporting continual improvement and ensuring that knowledge is maintained throughout the product lifecycle. Strong document governance therefore contributes not only to regulatory compliance but also to operational consistency across global manufacturing networks.
How poor document handling creates risk
Regulatory inspections continue to identify issues relating to incomplete records, inadequate documentation practices and failures to maintain appropriate controls over electronic information. Where inspectors cannot establish a reliable audit trail or determine which version of a document was in effect at a particular time, confidence in the associated manufacturing activities may also be affected.
The increasing reliance on electronic documentation has also brought greater attention to compliance with 21 CFR Part 11 requirements for electronic records and electronic signatures, which establish expectations for trustworthy, reliable and generally equivalent electronic records in FDA-regulated environments. Although Part 11 focuses on electronic systems, its underlying principles reinforce the importance of maintaining secure, traceable and controlled documentation throughout regulated processes.
Operational consequences can be equally significant. Poor document workflows may contribute to:
- Delays in batch release while missing documentation is located or corrected.
- Longer deviation and CAPA investigations due to incomplete audit trails.
- Increased administrative burden on quality assurance teams.
- Higher risk of confidential manufacturing information being shared inappropriately.
- Greater difficulty responding to customer audits or regulatory inspections.
How teams can build stronger document workflows
Improving document governance does not necessarily require organisations to replace existing quality systems. In many cases, meaningful improvements come from refining document processes and ensuring governance keeps pace with digital transformation.
Several practical approaches can strengthen compliance while improving operational efficiency.
Standardise document lifecycles
Every controlled document should follow a clearly defined process covering creation, review, approval, revision, distribution and archiving. Standardised workflows reduce ambiguity while making responsibilities easier to understand across departments.
Apply role-based access controls
Employees, contractors and external partners rarely require identical access to quality documentation. Restricting permissions according to organisational roles helps reduce unnecessary exposure of sensitive information while supporting compliance with internal governance policies.
Protect approved documentation
Once quality documents have been formally approved, organisations should ensure they cannot be modified outside authorised change-control processes. Appropriate document permissions, combined with version control and electronic approvals, help preserve record integrity while allowing legitimate access for operational use.
Maintain complete audit trails
Electronic systems should capture who created, reviewed, approved and modified each document, together with relevant timestamps. Comprehensive audit trails support investigations, simplify inspections and strengthen confidence in data integrity.
Train employees consistently
Even the most sophisticated document management system depends on consistent user behaviour. Regular training ensures employees understand document governance requirements, recognise common risks and follow approved workflows.
Review document governance regularly
Regulatory expectations, cybersecurity threats and business operations continue to evolve. Periodic reviews allow organisations to identify gaps before they affect compliance or inspection readiness, while ensuring document policies remain aligned with changing technologies and regulatory guidance.
Stronger document workflows support stronger compliance
Well-designed document workflows help ensure that critical information remains accurate, traceable and appropriately controlled from creation through long-term retention. They also reduce unnecessary administrative burden, strengthen collaboration across increasingly distributed manufacturing networks and improve confidence during inspections and audits.
Ultimately, successful compliance depends not only on producing accurate documents, but on maintaining trust in those documents throughout their entire lifecycle. Organisations that invest in stronger document governance today will be better positioned to meet evolving regulatory expectations while supporting the efficiency and reliability that modern pharmaceutical manufacturing demands.
Author Bio:
Emily Shaw
Founder of DocFly
Emily Shaw is the founder of DocFly, an online PDF editor. As a software developer, she built the site from scratch and is responsible for its operations and continued growth. Previously, she studied engineering at the University of Hong Kong and mathemat
Media Pack Download
Newsletters
Industrial Events
